A month is a long time on Wall Street. For one of 2020’s star performers, it has been a stark reminder how quickly sentiment can turn.Over the past month, shares of Inovio Pharmaceuticals (INO) have plummeted by 50% as the tides have turned against this high-flying coronavirus stock. Faced with stiff competition in the race to be first to market with a COVID-19 vaccine, investors have seemingly lost confidence in the small biotech’s ability to beat its bigger rivals.But not all on the Street have lowered expectations. Benchmark analyst Aydin Huseynov reiterated a Buy on INO shares alongside a $36 …read more
Source:: Yahoo Finance
